Gen. Mgr., Precision Oncology
Tue, Feb 21, 2023
Feb 21
exercised or converted securities in EXAS
1,729 shares @ $0.00
Decreased holdings by -33.30%
Net across this filing: +19.40% (+891 shares)
Option Exercise
Sale tied to a same-time option exercise
EXASEXACT SCIENCES CORP
Health CareHealth Care Services